Clinical Trial Results: A Clinical Study to Evaluate the Efficacy, Safety, and Tolerability of TERN-601 in Adults With Overweight or Obesity [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating efficacy, safety, and tolerability of TERN-601 in adults with overweight or obesity has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overweight or Obesity

Drugs mentioned

• TERN-601

Snippet

Sponsor: Terns, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | Conditions: Overweight or Obesity | Phase 2 | Status: COMPLETED | Results posted: 2026-08-10